SGLT2 inhibitors more cardioprotective in older versus younger people despite smaller reduction in HbA1c with older age ...

A new and increasingly widely used diabetes medication may have additional health benefits for older adults, according to new ...

Innogen, a Shanghai-based medical technology company, announced that its independently developed, human-derived, ...

A recent review shows who newer medications for type 2 diabetes may help the most, particularly in reducing the risk of ...

WEDNESDAY, Jan. 29, 2025 (HealthDay News) -- A popular diabetes drug just got a major new approval -- and it ... reduce the ...

The study offers promising news for people with type 2 diabetes. By using SGLT2 inhibitors, they may be able to lower their ...

A new study examines how cost, side effects, and other factors influence whether people stop GLP-1s, while Noom cuts staff to ...

A recent study from the University of Hong Kong suggests that a newer type of diabetes drug, called sodium-glucose cotransporter 2 inhibitors (SGLT2i), may help protect the kidneys and lungs in people ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

A majority with overweight/obesity discontinue within a year, but the rate is higher among those without type 2 diabetes.

New research found that over half of people with type 2 diabetes in the Americas may be deficient in essential nutrients, ...

Health experts are investigating a possible link between popular weight loss drugs like Ozempic and sudden blindness.